These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28647532)

  • 21. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.
    Livorsi DJ; Chorazy ML; Schweizer ML; Balkenende EC; Blevins AE; Nair R; Samore MH; Nelson RE; Khader K; Perencevich EN
    Antimicrob Resist Infect Control; 2018; 7():55. PubMed ID: 29719718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.
    Velasco JM; Valderama MT; Peacock T; Warawadee N; Nogrado K; Navarro FC; Chua D; Apichai S; Sirigade R; Macareo LR; Swierczewski B
    Emerg Infect Dis; 2017 Sep; 23(9):1597-1598. PubMed ID: 28820383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of varying federal definitions on prevalence and characteristics associated with carbapenem-resistant Enterobacteriaceae in veterans with spinal cord injury.
    Fitzpatrick MA; Suda KJ; Jones MM; Burns SP; Poggensee L; Ramanathan S; Evans M; Evans CT
    Am J Infect Control; 2019 Feb; 47(2):175-179. PubMed ID: 30301655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose.
    Savard P; Perl TM
    Clin Microbiol Infect; 2014 Sep; 20(9):854-61. PubMed ID: 24980472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notes from the Field: Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera - United States, 2014-2017.
    Walters MS; Witwer M; Lee YK; Albrecht V; Lonsway D; Rasheed JK; Anacker M; Snippes-Vagnone P; Lynfield R; Kallen AJ
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(23):668-669. PubMed ID: 29902165
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Rio Grande do Sul, Brazil.
    Lorenzoni VV; Silva DDC; Rampelotto RF; Brites PC; Villa B; Hörner R
    Rev Soc Bras Med Trop; 2017; 50(5):685-688. PubMed ID: 29160518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Most Dangerous Outbreak: New Delhi Metallo-β-Lactamase-1 Carbapenemase-Producing Enterobacteriaceae.
    O'Malley PA
    Clin Nurse Spec; 2020; 34(1):13-16. PubMed ID: 31789958
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey.
    Kostyanev T; Vilken T; Lammens C; Timbermont L; Van't Veen A; Goossens H
    Int J Antimicrob Agents; 2019 Mar; 53(3):268-274. PubMed ID: 30391381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.
    Pouch SM; Satlin MJ
    Virulence; 2017 May; 8(4):391-402. PubMed ID: 27470662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
    Muggeo A; Guillard T; Barbe C; Thierry A; Bajolet O; Vernet-Garnier V; Limelette A; Brasme L; De Champs C;
    J Antimicrob Chemother; 2017 May; 72(5):1496-1501. PubMed ID: 28158526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
    Drew RJ; Turton JF; Hill RL; Livermore DM; Woodford N; Paulus S; Cunliffe NA
    J Hosp Infect; 2013 Aug; 84(4):300-4. PubMed ID: 23831281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated.
    Lee BY; Bartsch SM; Wong KF; Kim DS; Cao C; Mueller LE; Gussin GM; McKinnell JA; Miller LG; Huang SS
    Infect Control Hosp Epidemiol; 2019 Jun; 40(6):731-734. PubMed ID: 30919795
    [No Abstract]   [Full Text] [Related]  

  • 36. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates.
    Tang HJ; Hsieh CF; Chang PC; Chen JJ; Lin YH; Lai CC; Chao CM; Chuang YC
    PLoS One; 2016; 11(3):e0151897. PubMed ID: 26999356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rapid spread of carbapenem-resistant Enterobacteriaceae.
    Potter RF; D'Souza AW; Dantas G
    Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.